Alkem wins ₹660 cr tax dispute, says no material impact
CIT Appeals deletes disallowances under Section 80-IE for five years, but the pharma major calls the sum immaterial relative to its ₹64,864 cr market cap.
— 2 earlier stories on Alkem Laboratories Ltd. →What's new
- CIT (Appeals) in Mumbai ruled in Alkem's favour on a multi-year tax dispute.
- ₹660.77 cr in disallowances under Section 80-IE have been deleted for five assessment years.
- The company says the order has no material impact on financials or operations.
Why this matters
The order removes a legacy tax overhang, but the ₹660 cr is less than 1% of Alkem's market cap. With ₹3,603 cr in quarterly sales and net profit of ₹252 cr, the tax relief changes nothing on earnings or valuation. It's a clean-up, not a catalyst.
What we're watching
- Whether the tax department appeals this decision further.
- Any impact on tax provisions already booked – Alkem hasn't clarified if provisions were made.
- Whether the company uses any cash savings for shareholder returns.
The full read
Alkem Laboratories won a tax appeal deleting ₹660.77 crore in disallowances under Section 80-IE for five assessment years. The Commissioner of Income Tax (Appeals) in Mumbai ruled for the company, overturning the assessing officer's reassessment orders. But Alkem says the order has no material impact on its financials or operations. Hardly surprising. ₹660 crore is less than 1% of Alkem's ₹64,864 crore market cap, and against quarterly sales of ₹3,603 crore and net profit of ₹252 crore, the relief is a rounding error. The order removes a legal overhang but does not change the investment thesis — the open question is whether the tax department will appeal, dragging the dispute further. Even if it doesn't, this is a clean-up, not a catalyst.
Questions answered
- What was the tax dispute about?
- The assessing officer had disallowed claims under Section 80-IE, which provides tax deductions for eligible businesses. The CIT (Appeals) overturned these disallowances for assessment years 2018-19 to 2022-23.
- Why does Alkem say the order has no material impact?
- At a market cap of ₹64,864 cr, the ₹660.77 cr disallowance is less than 1% of the company's value. The company likely had already provided for the liability or deemed it immaterial against its overall financials.
- Could the tax department appeal this order?
- Yes. The order is by the first appellate authority. The income-tax department may file an appeal before the Income Tax Appellate Tribunal (ITAT). Alkem's relief is not final until all appeals are exhausted.
- Does this affect Alkem's earnings estimates?
- Unlikely. Even if the entire amount were to flow back as cash tax saved, it's too small relative to Alkem's ₹1,008 cr annual net profit (trailing four quarters) to prompt revisions.
Alkem Laboratories Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on ALKEM →- 1 Jul 2026 · 4:59 PM IST Alkem wins ₹660 cr tax dispute, says no material impact
- 33d ago Alkem promoter trust sells ₹288 cr stake, says cash goes to beneficiaries
- 34d ago Alkem undercuts pen injectors with India's first ₹350 semaglutide syringe